This presentation by Dr Weisenseel considered the role of fumaric acid esters (FAE) in plaque psoriasis. FAE, first developed in 1959 and approved in 1994, are available in two forms: dimethyl fumarate (DMF) alone (e.g. Skilarence®; Almirall Ltd., Uxbridge, UK) or DMF together with calcium, zinc, and magnesium salts of monoethyl fumarate (Fumaderm®).
EMJ Dermatology 6 [Suppl 2] . 2019
Latest articles
All articles
5 Mins
4th
March
Unpacking the Skin Microbiome: Richard Gallo
AMJ is delighted to welcome Richard Gallo, Professor and Chair of Dermatology at the University of California San Diego, USA. A leading…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
6 Mins
15th
January
Nail Psoriasis: Manifestations, Diagnosis, and Management
Psoriasis is a common, chronic inflammatory dermatosis, and patients with psoriasis often develop nail involvement. It is estimated that…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.